Medicis Pharmaceutical Corp. (MRX) [Chart - Analysis - News] released its most recent earnings statement about a month ago on Thursday, August 5th. Medicis Pharmaceutical Corp. beat expectations with a profit of 56 cents per share---6 cents above the analyst consensus of 50 cents per share. MRX also issued earnings guidance for next quarter that was above current analyst expectations.
Now that investors have had plenty of time to assimilate the information and update their positions, it's time to take another look at Medicis Pharmaceutical Corp.
MRX has done pretty well since its earnings announcement. It has gained $2.72 (10.12 percent) during the past month and is currently trading above its 20-day, 50-day and 200-day moving averages.
Of course, all of this movement is not attributable to the company alone. To see what other factors might be affecting MRX's performance, it's helpful to compare its price movement to the movement of other individual stocks within the industry group and to that of its industry group as a whole.
Now that investors have had plenty of time to assimilate the information and update their positions, it's time to take another look at Medicis Pharmaceutical Corp.
MRX has done pretty well since its earnings announcement. It has gained $2.72 (10.12 percent) during the past month and is currently trading above its 20-day, 50-day and 200-day moving averages.
Of course, all of this movement is not attributable to the company alone. To see what other factors might be affecting MRX's performance, it's helpful to compare its price movement to the movement of other individual stocks within the industry group and to that of its industry group as a whole.
No comments:
Post a Comment